Regulatory update #249

24 April 2017

Kareena Arthy resigns as APVMA CEO

On Friday 21 April the APVMA issued a statement to inform clients and stakeholders that Kareena Arthy would be resigning from the position of Chief Executive Officer at the APVMA. After four years with the agency, Ms Arthy has made the difficult decision to take up a new opportunity as Deputy Director General in ACT Chief Minister, Treasury and Economic Development Directorate.

Ms Arthy’s resignation is effective from 31 May 2017. The future leadership of the APVMA is a matter for the Deputy Prime Minister. 

The APVMA thanks Ms Arthy for her strong leadership and commitment to regulatory excellence.

Guide to completing an online application

We have new guidance material to assist applicants when completing an online application. The guide was developed following feedback provided by our clients at the 2016 industry events and incorporates suggestions from our usability review of APVMA Online services and Thanks to everyone who took part in the review and provided the feedback we needed to improve our services and guidance material.

Check out the guide and let us know how we might continue to improve our online information. You can provide your comments through the ‘feedback’ link on the bottom of each webpage or by emailing

Well done industry—Trifluralin complies

The APVMA Compliance and Monitoring team are very pleased with recent testing results for trifluralin active and registered chemical products containing trifluralin.

In December 2016, APVMA inspectors undertook random sampling of trifluralin active constituents and trifluralin products across Victoria. Samples were obtained from agricultural chemical manufacturers and submitted to an authorised laboratory for chemical analysis.

The results show that the trifluralin active constituents comply with the APVMA Standard for both active and impurity concentrations. The testing also confirms that the concentration of active constituent in the registered chemical products complies with the particulars detailed in the APVMA Register.

In line with the APVMA’s Annual Compliance Plan 2016–17 we will soon commence sampling and testing of meloxicam and fipronil samples.

Once again, well done industry on this excellent result!

Scheduling Policy Framework Review open for consultation

The Therapeutic Goods Administration (TGA) is seeking comments from interested parties on the review of the Scheduling Policy Framework and reforms to advertising of pharmacist-only medicines (Schedule 3 substances). Consultation closes Friday 28 April 2017.

Visit the TGA website to view the Schedule Policy Framework Review consultation paper and make a formal submission. Any questions about submissions should be directed to the TGA's Regulatory Reforms team at


Read the latest Advice Summaries and Application Summaries.

Reminder—open for public consultation

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.